Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,729.00
Bid: 1,728.50
Ask: 1,729.00
Change: 0.50 (0.03%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Meggitt, GlaxoSmithKline, Luxury goods

Sun, 15th Aug 2021 17:08

(Sharecast News) - Ministers must be prepared to block a takeover of Meggitt if any bidder tries to buy it without giving binding commitments on investment and jobs, the FTSE 250 aerospace and defence manufacturer's chairman warned this weekend. Sir Nigel Rudd said that while "clearly, price is important", any new owner would need to give Meggitt and the government undertakings, including to keep the company's headquarters in Coventry and maintain R&D spending. - Sunday Times

A legal battle between Britain's two pharma champions has escalated after Glaxo Smith Kline launched a counter-claim against rival Astra Zeneca. It revolves around sales of Glaxo's top-selling cancer drug, Zejula, a treatment for ovarian and other cancers. Astra licenses the underlying technology to Glaxo, and claims it should receive a greater share of Zejula's sales. It accused Glaxo of breaching the terms of its agreement and has hired accountants KPMG to audit Zejula's sales. A source suggested the claim could reach hundreds of millions of pounds. - Sunday Times

The fortunes of the world's biggest luxury goods groups have been lifted by a splurge on expensive jewellery, watches, fashion and champagne as billions in spare cash is spent on big-budget treats. Sales at 11 of the largest luxury groups and their brands have grown by a fifth on average compared with 2019, before the pandemic began. And they have more than doubled on last year. - Financial Mail on Sunday

Talks to get the US investment giant Apollo on board to finance a bid to buy Morrisons have cooled after a shock increase in the offer price earlier this month. New York-based Apollo had been lined up to join a takeover consortium led by the private equity firm Fortress. But market sources this weekend said they believed Apollo had baulked at the dramatic £400 million price increase for the supermarket chain. - Financial Mail on Sunday

The magazine publisher behind The Week is on the verge of being sold to Future, the FTSE 250- listed media group. Future, which also owns Marie Claire and football magazine FourFourTwo, is in 'advanced' discussions with the private equity owners of Dennis Publishing about a takeover of a large number of the company's most well-known publications. - Financial Mail on Sunday

Imposing "premature austerity" again will undermine the fight against climate change and stop poorer households going green, one of the world's leading climate economists has warned the government, amid claims that the Treasury is resisting policies to tackle the crisis. Nicholas Stern, the author of the seminal 2006 government study into the costs of climate change, said comprehensive programmes were needed to help poorer households make the switch to electric cars and away from gas heating, if the government hoped to bring all greenhouse gas emissions to net zero by 2050. - Guardian

BT is threatening to crush competition and slow Britain's upgrade to faster full-fibre broadband by bringing in unfair prices, Virgin Media O2 has warned. The newly merged telecoms giant claims discounts being offered to broadband retailers buying access to the new network set a "dangerous precedent" that will scupper investment. - Sunday Telegraph

Amazon is adding own-brand groceries to its UK website to bolster its online offering, as the retail titan steps up its assault on British supermarkets. The business will allow shoppers to add hundreds of "By Amazon" and "Our Selection" products to their virtual baskets in the coming weeks. Bosses are expected to launch an advertising blitz to promote the ranges as they seek to attract more customers to its Fresh service, sources said. - Sunday Telegraph

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.